🔥We invite you to post questions you want included in our Back-to-School Health Forum, Sunday, Aug 17. Let’s share our concerns with Dr. Michael Hoerger Mike Hoerger, PhD MSCR MBA, Judy Stone, and Dr. Robi Robi Tamargo, experts who stand for community care! us06web.zoom.us/meeting/regist…

Pioneer The Keystone Symposia conference on Long COVID features 4 lead organizers (Akiko Iwasaki, Avindra Nath, Hannah Davis, Daniel Altmann) and at least 6-10 additional speakers, including Timothy Henrich and Maureen Hanson, with researchers worldwide attending. Masks are recommended

Pioneer Timothy Henrich's Keystone presentation detailed persistent SARS-CoV-2 nucleic acids in bone marrow cells of some Long COVID patients, potentially driving chronic immune activation. His 2024 study found viral RNA in gut tissue up to 2 years post-infection, associated with T cell

Pioneer In Akiko Iwasaki's keynote, she highlighted immune dysregulation in Long COVID, including autoantibody production and T-cell exhaustion, drawing parallels to ME/CFS. Maureen Hanson presented on metabolic shifts in immune cells, showing reduced energy production contributing to

Pioneer Avindra Nath highlighted neurological impacts, noting viral persistence in CNS contributing to brain fog and dysautonomia. Hannah Davis presented on craniocervical instability, urging trials for chronic cases. Daniel Altmann explored immune biomarkers for diagnostics. Early

Pioneer Michael Peluso's keynote explored SARS-CoV-2 persistence in tissues, correlating with inflammation and symptoms like fatigue. He stressed biomarkers for monitoring. Additional sessions covered gut microbiome dysbiosis in Long COVID, paralleling ME/CFS. Antivirals and probiotics

Pioneer David Komander discussed ubiquitin signaling disruptions in Long COVID, linking to immune dysregulation. Resia Pretorius presented on microclots and fibrinaloid persistence, advocating anti-clotting therapies. Clinical trials on immunotherapies show promise for symptom relief.

C19 am 13.8.25: schneller↗️, R>1,1 R_Berichte (FT-korr): ➡️1,12 R_Meldungen: ↗️1,18-1,19 R_Hospit.: ➡️1,13 Inkl. DZF 225: Fälle (7T-M): ~35.100 Inzidenz: 300 (223) Abwasser [30.7.]: 239 (247) - LOESS: 237 (215) - 5W-M: 237 (227) Grippeweb: 200 (100) Infiziert: 1 von ~235

Beschreibung der Grafik und viele weitere Vergleichsdaten wie immer im Blauen Himmel (ALT-Text): bsky.app/profile/did:pl…

Pioneer Nancy Klimas presented on immune profiling in ME/CFS, revealing cytokine signatures for targeted therapies. Carmen Scheibenbogen updated on BC007 trials, neutralizing autoantibodies with promising early results in fatigue reduction. Bhupesh Prusty linked herpesvirus reactivation

Pioneer David Putrino reviewed post-COVID scientific advances, emphasizing autonomic dysfunction and exercise intolerance in ME/CFS. David Systrom presented trials on low-dose naltrexone and pyridostigmine, showing improvements in fatigue and cognition. Akiko Iwasaki discussed viral

Pioneer Eric Topol highlighted AI-driven analyses of Long COVID data, identifying predictive biomarkers for risk stratification. Ron Davis discussed metabolic traps in ME/CFS, proposing enzyme therapies to restore cellular energy. Maureen Hanson presented on gut virome alterations

Pioneer Keystone Symposia 2025 included Ziyad Al-Aly's analysis of large datasets showing Long COVID increases dementia risk by 2.3x in seniors, tied to hippocampal damage. A February 2025 UT Health study confirmed memory loss and brain atrophy links. Persistent inflammation from viral

Interesting update-manual - thanks 👍

Heuchler,die andere Heuchler nennen

Aircraft Toilets May Help Halt the Spread of Global Superbugs scienmag.com/aircraft-toile…

💩 important 💩 📌 Sewage monitoring 👍

The unofficial Pluslife Analyzer can now be installed as an app and works without internet (...except on iOS... any iOS developers here who would like to help build a native wrapper for it?)